Loxo Oncology Inc. (LOXO) Surged To A New High On Study Results

Loxo Oncology Inc. (LOXO) announced after the bell Wednesday that preliminary results from a Phase 1 trial showed that its LOXO-292 drug shrank tumors in nearly 70 percent of patients.

from RTT - Before the Bell https://ift.tt/2wU2h9K
via IFTTT